{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:53:39Z","timestamp":1769151219027,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pence foundation"},{"DOI":"10.13039\/100006817","name":"University of Wisconsin-Milwaukee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006817","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Milwaukee Institute of Drug Discovery"},{"name":"University of Wisconsin-Milwaukee Research Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.pbb.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:58:07Z","timestamp":1551268687000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The \u03b12,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats"],"prefix":"10.1016","volume":"180","author":[{"given":"J.M.","family":"Witkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cerne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.G.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.B.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Methuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.D.","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Krambis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Poe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Schkeryantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.K.","family":"Golani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"Catlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.L.","family":"Knopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pbb.2019.02.013_bb0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/j.pain.0000000000000458","article-title":"Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations","volume":"157","author":"Andrews","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2019.02.013_bb0010","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2174\/156802611795371350","article-title":"GABAA receptor subtype-selective modulators. I. \u03b12\/\u03b13-selective agonists as non-sedating anxiolytics","volume":"11","author":"Atack","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pbb.2019.02.013_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0269881109354928","article-title":"Preclinical and clinical pharmacology of TPA023B, a GABAA receptor alpha;2\/alpha;3 subtype-selective partial agonist","volume":"25","author":"Atack","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2019.02.013_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/sja.SJA_141_17","article-title":"Which is better for pain reduction during transrectal ultrasound-guided biopsy of the prostate: intravenous diazepam, local periprostatic nerve block, or combination? Controlled randomized study","volume":"12","author":"Atta","year":"2018","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.pbb.2019.02.013_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000435939","article-title":"Generalized anxiety disorder and pain","volume":"30","author":"Bandelow","year":"2015","journal-title":"Mod. Trends Pharmacopsychiat."},{"issue":"4","key":"10.1016\/j.pbb.2019.02.013_bb0030","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apha.12394","article-title":"Activation of the brain melancortin system is required for leptin-induced modulation of chemorespiratory function","volume":"213","author":"Bassi","year":"2015","journal-title":"Acta Physiol."},{"issue":"3","key":"10.1016\/j.pbb.2019.02.013_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.j.pain.0000460331.33385.e8","article-title":"GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers","volume":"156","author":"Besson","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2019.02.013_bb0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0026-895X(25)08763-2","article-title":"Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylic acid","volume":"49","author":"Bleakman","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2019.02.013_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/adt.2015.677","article-title":"Optimization of a high-throughput assay for calcium channel modulators on ionworks barracuda","volume":"14","author":"Cerne","year":"2016","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.pbb.2019.02.013_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2019.02.013_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(95)01063-7","article-title":"Time-related roles of excitatory amino acid receptors during persistent noxiously evoked responses of rat dorsal horn neurones","volume":"703","author":"Chapman","year":"1995","journal-title":"Brain Res."},{"issue":"100","key":"10.1016\/j.pbb.2019.02.013_bb0060","first-page":"279","article-title":"GABAA receptor associated proteins: a key factor regulating GABAA receptor function","volume":"2007","author":"Chen","year":"2006","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.pbb.2019.02.013_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)12039-9","article-title":"Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model","volume":"275","author":"Dirig","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.02.013_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(06)54001-3","article-title":"The role of GABA in the mediation and perception of pain","volume":"54","author":"Enna","year":"2006","journal-title":"Adv. Pharmacol."},{"issue":"46","key":"10.1016\/j.pbb.2019.02.013_bb0075","doi-asserted-by":"crossref","first-page":"11634","DOI":"10.1523\/JNEUROSCI.2301-16.2016","article-title":"Functional synaptic integration of forebrain GABAergic precursors into the adult spinal cord","volume":"36","author":"Etlin","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2019.02.013_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2017.03.001","article-title":"Pharmacological and antihyperalgesic properties of the novel \u03b12\/3 preferring GABAA receptor ligand MP-III-024","volume":"131","author":"Fischer","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.pbb.2019.02.013_bb0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neures.2011.10.004","article-title":"New method to discriminate sedative and analgesic effects of drugs in the automated formalin test in rats","volume":"72","author":"Gr\u00e9goire","year":"2012","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pbb.2019.02.013_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02246664","article-title":"The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 selective, benzodiazepine receptor ligands","volume":"124","author":"Griebel","year":"1996","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2019.02.013_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(84)90197-3","article-title":"Effects of intrathecally administered THIP, baclofen and muscimol on nociceptive threshold","volume":"103","author":"Hammond","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.02.013_bb0100","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.8b00611","article-title":"In vivo quantitative understanding of PEGylated liposome's influence on brain delivery of diphenhydramine","author":"Hu","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.pbb.2019.02.013_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2125.2004.02089.x","article-title":"Alprazolam is relatively more toxic than other benzodiazepines in overdose","volume":"58","author":"Isbister","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2019.02.013_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J. Pharm. Pract."},{"issue":"9","key":"10.1016\/j.pbb.2019.02.013_bb0115","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bph.13740","article-title":"Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2\/3 receptor agonist LY2934747, in rodent pain models","volume":"174","author":"Johnson","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2019.02.013_bb0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/j.pain.0000000000001392","article-title":"Positive allosteric modulators of nonbenzodiazepine \u03b3-aminobutyric acidA receptor subtypes for the treatment of chronic pain","volume":"160","author":"Johnstone","year":"2019","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pbb.2019.02.013_bb8000","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500039","article-title":"Therapy using implanted organic bioelectronics","volume":"1","author":"Jonsson","year":"2015","journal-title":"Sci Adv."},{"key":"10.1016\/j.pbb.2019.02.013_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2017.01.021","article-title":"Neonatal bladder inflammation induces long-term visceral pain and altered responses of spinal neurons in adult rats","volume":"346","author":"Kannampalli","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pbb.2019.02.013_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pain.2008.10.015","article-title":"Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice","volume":"141","author":"Knabl","year":"2009","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.pbb.2019.02.013_bb0135","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acschemneuro.6b00447","article-title":"Antinociceptive effects of a novel \u03b12\/\u03b13-subtype selective GABAA receptor positive allosteric modulator","volume":"8","author":"Lewter","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"20","key":"10.1016\/j.pbb.2019.02.013_bb0140","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1055\/s-0037-1610211","article-title":"Improved synthesis of anxiolytic, anticonvulsant and antinociceptive \u03b12\/\u03b13-GABA(A)ergic receptor subtype selective ligands as promising agents to treat anxiety, epilepsy, as well as neuropathic pain","volume":"50","author":"Li","year":"2018","journal-title":"Synthesis"},{"issue":"32","key":"10.1016\/j.pbb.2019.02.013_bb0145","first-page":"2492","article-title":"Expression of gamma-aminobutyric acid type A receptor \u03b12 subunit in the dorsal root ganglion of rats with sciatic nerve injury","volume":"7","author":"Lian","year":"2012","journal-title":"Neural Regen. Res."},{"issue":"24","key":"10.1016\/j.pbb.2019.02.013_bb0150","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1523\/JNEUROSCI.0159-14.2014","article-title":"Gephyrin clusters are absent from small diameter primary afferent terminals despite the presence of GABA(A) receptors","volume":"34","author":"Lorenzo","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2019.02.013_bb0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2019.02.013_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2018.04.009","article-title":"An antidepressant-related pharmacological signature for positive allosteric modulators of \u03b12\/3-containing GABAA receptors","volume":"170","author":"Methuku","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.02.013_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/FBP.0000000000000464","article-title":"Effects of the \u03b12\/\u03b13-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam","author":"Moerke","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2019.02.013_bb0180","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bph.14119","article-title":"Pharmacology in translation; the preclinical and early clinical profile of the novel \u03b12\/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865","volume":"175","author":"Nickolls","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.pbb.2019.02.013_bb0185","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1097\/j.pain.0000000000000695","article-title":"Hedonic and motivational responses to food reward are unchanged in rats with neuropathic pain","volume":"157","author":"Okun","year":"2016","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pbb.2019.02.013_bb0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14728214.2016.1257605","article-title":"Emerging drugs for diabetic peripheral neuropathy and neuropathic pain","volume":"21","author":"Papanas","year":"2016","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"17","key":"10.1016\/j.pbb.2019.02.013_bb0195","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1002\/cne.23129","article-title":"Selective distribution of GABA(A) receptor subtypes in mouse spinal dorsal horn neurons and primary afferents","volume":"520","author":"Paul","year":"2012","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"10.1016\/j.pbb.2019.02.013_bb0200","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/npp.2013.221","article-title":"Antihyperalgesia by \u03b12-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites","volume":"39","author":"Paul","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.02.013_bb0205","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1021\/acs.jmedchem.6b01332","article-title":"Synthesis and characterization of a novel GABAA receptor ligand, 5-(8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepin-3-yl)oxazole (KRM-II-81), that combines exceptional drug stability, pharmacokinetics, and anxiolytic efficacy","volume":"59","author":"Poe","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2019.02.013_bb0210","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1038\/ncomms7803","article-title":"Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype","volume":"6","author":"Ralvenius","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbb.2019.02.013_bb0215","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuropharm.2016.07.004","article-title":"The clobazam metabolite N-desmethyl clobazam is an \u03b12 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia","volume":"109","author":"Ralvenius","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2019.02.013_bb0220","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/s41467-018-05709-0","article-title":"Itch suppression in mice and dogs by modulation of spinal \u03b12 and \u03b13GABAA receptors","volume":"9","author":"Ralvenius","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.pbb.2019.02.013_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0773.1987.tb01786.x","article-title":"The effect of diazepam on nociception in mice","volume":"61","author":"Rosland","year":"1987","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.pbb.2019.02.013_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneumeth.2014.06.001","article-title":"A method to enhance the magnitude of tactile hypersensitivity following spinal nerve ligation in rats","volume":"233","author":"Simmons","year":"2014","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.pbb.2019.02.013_bb8005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"issue":"65(10)","key":"10.1016\/j.pbb.2019.02.013_bb0235","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010\u20132014","volume":"2016","author":"Warner","year":"2016","journal-title":"Natl. Vital Stat. Rep."},{"key":"10.1016\/j.pbb.2019.02.013_bb0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pbb.2017.04.009","article-title":"Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for \u03b12\/3-containing GABAA receptors","volume":"157","author":"Witkin","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.02.013_bb0245","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2018.05.006","article-title":"Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABAA receptors: improved bioavailability enhances anticonvulsant efficacy","volume":"137","author":"Witkin","year":"2018","journal-title":"Neuropharmacology"},{"issue":"22","key":"10.1016\/j.pbb.2019.02.013_bb8010","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1523\/JNEUROSCI.6328-10.2011","article-title":"Presynaptic alpha2-GABAA receptors in primary afferent depolarization and spinal pain control","volume":"31","author":"Witschi","year":"2011","journal-title":"J Neurosci."},{"key":"10.1016\/j.pbb.2019.02.013_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lfs.2017.09.033","article-title":"Research progress of mechanisms and drug therapy for neuropathic pain","volume":"190","author":"Yan","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2019.02.013_bb0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.apha.2014.11.007","article-title":"Restoring the spinal pain gate: GABA(A) receptors as targets for novel analgesics","volume":"73","author":"Zeilhofer","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pbb.2019.02.013_bb0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0269881115620435","article-title":"NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects","volume":"30","author":"Zuiker","year":"2016","journal-title":"J. Psychopharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718306348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718306348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:35:08Z","timestamp":1758774908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718306348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":53,"alternative-id":["S0091305718306348"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.02.013","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b12,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}